Florian Franz

1.3k total citations
29 papers, 1.0k citations indexed

About

Florian Franz is a scholar working on Toxicology, Pharmacology and Clinical Psychology. According to data from OpenAlex, Florian Franz has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Toxicology, 18 papers in Pharmacology and 10 papers in Clinical Psychology. Recurrent topics in Florian Franz's work include Forensic Toxicology and Drug Analysis (22 papers), Cannabis and Cannabinoid Research (18 papers) and Psychedelics and Drug Studies (10 papers). Florian Franz is often cited by papers focused on Forensic Toxicology and Drug Analysis (22 papers), Cannabis and Cannabinoid Research (18 papers) and Psychedelics and Drug Studies (10 papers). Florian Franz collaborates with scholars based in Germany, United Kingdom and Switzerland. Florian Franz's co-authors include Volker Auwärter, Verena Angerer, Bjoern Moosmann, Annelies Cannaert, Christophe P. Stove, Laura M. Huppertz, Philippe Bisel, Lukas Mogler, Jörg Pietsch and Maren Hermanns‐Clausen and has published in prestigious journals such as Nature Communications, Analytical Chemistry and The Journal of Physical Chemistry B.

In The Last Decade

Florian Franz

29 papers receiving 1.0k citations

Peers

Countries citing papers authored by Florian Franz

Since Specialization

Citations

This map shows the geographic impact of Florian Franz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Franz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Franz more than expected).

Fields of papers citing papers by Florian Franz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Franz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Franz. The network helps show where Florian Franz may publish in the future.

Co-authorship network of co-authors of Florian Franz

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Franz. A scholar is included among the top collaborators of Florian Franz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Franz. Florian Franz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Allosteric activation of vinculin by talin 2023 ·Nature Communications ·Florian Franz, Rafael Tapia‐Rojo, Sabina Winograd‐Katz, Rajaa Boujemaa‐Paterski, Wenhong Li, Tamar Unger, Shira Albeck, Camilo Aponte‐Santamaría, Sergi Garcia-Manyes, Ohad Medalia, Benjamin Geiger, Frauke Gräter	20
2	Acute psychotropic, autonomic, and endocrine effects of 5,6‐methylenedioxy‐2‐aminoindane (MDAI) compared with 3,4‐methylenedioxymethamphetamine (MDMA) in human volunteers: A self‐administration study 2023 ·Drug Testing and Analysis ·Verena Angerer, Yasmin Schmid, Florian Franz, Heike Gnann, (unknown), (unknown), (unknown), Armin Buchwald, Simon D. Brandt, Torsten Passie, Matthias E. Liechti, Volker Auwärter	3
3	Intrinsically disordered region of talin’s FERM domain functions as an initial PIP2 recognition site 2023 ·Biophysical Journal ·(unknown), Florian Franz, Frauke Gräter	2
4	Advances in molecular simulations of protein mechanical properties and function 2020 ·Current Opinion in Structural Biology ·Florian Franz, Csaba Daday, Frauke Gräter	25
5	Extraordinary long detection window of a synthetic cannabinoid metabolite in human urine – Potential impact on therapeutic decisions 2020 ·Drug Testing and Analysis ·Florian Franz, (unknown), Leslie A. King, Volker Auwärter	11
6	Detection and phase I metabolism of the 7‐azaindole‐derived synthetic cannabinoid 5F‐AB‐P7AICA including a preliminary pharmacokinetic evaluation 2019 ·Drug Testing and Analysis ·Arianna Giorgetti, Lukas Mogler, (unknown), Sebastian Halter, Florian Franz, Folker Westphal, (unknown), (unknown), Michael Pütz, Volker Auwärter	20
7	Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE 2018 ·Forensic Toxicology ·Lukas Mogler, Sebastian Halter, Maurice Wilde, Florian Franz, Volker Auwärter	21
8	5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA 2018 ·Forensic Toxicology ·Verena Angerer, Florian Franz, Bjoern Moosmann, Philippe Bisel, Volker Auwärter	32
9	Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation 2018 ·International Journal of Legal Medicine ·(unknown), Andreas Thomas, (unknown), Florian Franz, Volker Auwärter, Mario Thevis, Katja Mercer‐Chalmers‐Bender	8
10	Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS 2018 ·Current Pharmaceutical Biotechnology ·Melanie Hutter, Sebastian Broecker, Stefan Kneisel, Florian Franz, Simon D. Brandt, Volker Auwärter	12
11	Synthetic cannabinoids in hair – Pragmatic approach for method updates, compound prevalences and concentration ranges in authentic hair samples 2018 ·Analytica Chimica Acta ·Florian Franz, (unknown), Verena Angerer, (unknown), Volker Auwärter, Merja A. Neukamm	29
12	Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL‐PEGACLONE and detection in human urine samples 2018 ·Drug Testing and Analysis ·Lukas Mogler, Maurice Wilde, Laura M. Huppertz, (unknown), Florian Franz, Volker Auwärter	28
13	Activity-Based Detection of Consumption of Synthetic Cannabinoids in Authentic Urine Samples Using a Stable Cannabinoid Reporter System 2017 ·Analytical Chemistry ·Annelies Cannaert, Florian Franz, Volker Auwärter, Christophe P. Stove	85
14	Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA 2017 ·Clinical Toxicology ·Maren Hermanns‐Clausen, Dieter Müller, (unknown), Verena Angerer, Florian Franz, Florian Eyer, Hartmud Neurath, (unknown), Volker Auwärter	54
15	Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA 2017 ·Forensic Science International ·Verena Angerer, (unknown), Florian Franz, Volker Auwärter, Jörg Pietsch	80
16	Immunoassay screening in urine for synthetic cannabinoids – an evaluation of the diagnostic efficiency 2017 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Florian Franz, Verena Angerer, (unknown), (unknown), (unknown), (unknown), (unknown), Christian Schlögl, (unknown), (unknown), (unknown), (unknown), Matthias Wagner, Bjoern Moosmann, Volker Auwärter	45
17	Detection of the recently emerged synthetic cannabinoid 5F–MDMB‐PICA in ‘legal high’ products and human urine samples 2017 ·Drug Testing and Analysis ·Lukas Mogler, Florian Franz, Daniel Rentsch, Verena Angerer, (unknown), Mitchell Longworth, Samuel D. Banister, Michael Kassiou, Bjoern Moosmann, Volker Auwärter	87
18	Metabolites of synthetic cannabinoids in hair—proof of consumption or false friends for interpretation? 2016 ·Analytical and Bioanalytical Chemistry ·Florian Franz, Verena Angerer, Maren Hermanns‐Clausen, Volker Auwärter, Bjoern Moosmann	48
19	Adverse effects after the use of JWH‐210 – a case series from the EU Spice II plus project 2016 ·Drug Testing and Analysis ·(unknown), (unknown), (unknown), Verena Angerer, Florian Franz, Florian Eyer, Volker Auwärter	41
20	Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay 2016 ·Analytical Chemistry ·Annelies Cannaert, (unknown), Florian Franz, Volker Auwärter, Christophe P. Stove	147

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact